tiprankstipranks
Miricor Enterprises Holdings Ltd (HK:1827)
:1827
Hong Kong Market

Miricor Enterprises Holdings Ltd (1827) AI Stock Analysis

0 Followers

Top Page

HK:1827

Miricor Enterprises Holdings Ltd

(1827)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 5.2)
Rating:62Neutral
Price Target:
HK$0.71
▼(-25.26% Downside)
Action:ReiteratedDate:03/24/26
The score is driven primarily by improving financial performance, especially strong cash flow and a return to profitability, supported by constructive technical momentum with price above key moving averages. These positives are moderated by a demanding valuation (high P/E) and recent revenue contraction and earnings volatility, which increase durability risk.
Positive Factors
Cash generation
Strong operating and free cash flow in 2025, with FCF nearly matching net income, indicates high earnings quality and internal funding capacity. Durable cash generation supports reinvestment in clinics, product inventory, or debt reduction and provides a buffer through cyclical dips, improving financial flexibility over the medium term.
Negative Factors
Revenue contraction
A 2025 revenue decline (~6%) and prior multi-year volatility indicate demand or volume weakness. Persistent top-line contraction undermines operating leverage, limits ability to scale high-margin services, and makes sustaining recent profit improvements harder without clear, durable revenue recovery drivers over the next several months.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash generation
Strong operating and free cash flow in 2025, with FCF nearly matching net income, indicates high earnings quality and internal funding capacity. Durable cash generation supports reinvestment in clinics, product inventory, or debt reduction and provides a buffer through cyclical dips, improving financial flexibility over the medium term.
Read all positive factors

Miricor Enterprises Holdings Ltd (1827) vs. iShares MSCI Hong Kong ETF (EWH)

Miricor Enterprises Holdings Ltd Business Overview & Revenue Model

Company Description
Miricor Enterprises Holdings Limited, an investment holding company, provides medical aesthetic services in Hong Kong. It also offers a range of non-surgical medical aesthetic services, including energy-based and injection procedures. The company ...
How the Company Makes Money
Miricor Enterprises Holdings Ltd generates revenue primarily through the provision of medical aesthetic services. The company charges clients for non-invasive aesthetic treatments performed at its centers, which include consultations, customized p...

Miricor Enterprises Holdings Ltd Financial Statement Overview

Summary
Financials are improving, led by strong 2025 operating and free cash flow and a return to profitability after losses in 2023–2024. Offsetting this, 2025 revenue declined (~6%) and earnings have been volatile across recent years, which tempers confidence in the durability of the recovery.
Income Statement
56
Neutral
Balance Sheet
62
Positive
Cash Flow
74
Positive
BreakdownMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income Statement
Total Revenue403.15M494.26M463.12M363.92M128.87M
Gross Profit211.13M225.37M238.23M209.54M44.99M
EBITDA106.36M86.62M70.34M94.02M16.93M
Net Income10.59M-12.62M-20.50M25.38M-12.65M
Balance Sheet
Total Assets471.28M479.44M516.81M476.81M372.13M
Cash, Cash Equivalents and Short-Term Investments192.17M182.43M179.32M128.16M161.77M
Total Debt88.76M99.75M130.28M127.58M42.49M
Total Liabilities323.72M342.68M366.10M305.54M226.56M
Stockholders Equity147.56M136.76M150.71M171.27M145.57M
Cash Flow
Free Cash Flow112.07M58.24M72.67M-67.61M19.07M
Operating Cash Flow114.02M84.45M99.45M44.03M24.54M
Investing Cash Flow-30.95M-59.00M-37.84M-97.51M52.20M
Financing Cash Flow-50.03M-55.59M-21.92M-28.73M-14.65M

Miricor Enterprises Holdings Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.95
Price Trends
50DMA
0.83
Positive
100DMA
0.90
Negative
200DMA
0.97
Negative
Market Momentum
MACD
0.03
Positive
RSI
51.70
Neutral
STOCH
92.60
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1827, the sentiment is Negative. The current price of 0.95 is above the 20-day moving average (MA) of 0.89, above the 50-day MA of 0.83, and below the 200-day MA of 0.97, indicating a neutral trend. The MACD of 0.03 indicates Positive momentum. The RSI at 51.70 is Neutral, neither overbought nor oversold. The STOCH value of 92.60 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1827.

Miricor Enterprises Holdings Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
HK$700.97M7.7123.07%5.98%-0.19%19.04%
66
Neutral
HK$1.41B4.6039.78%9.92%-23.31%-44.61%
63
Neutral
HK$4.74B21.3157.32%56.28%-9.91%
62
Neutral
HK$268.00M24.6311.41%-20.59%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
53
Neutral
HK$75.98M2.5910.10%-3.40%515.63%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1827
Miricor Enterprises Holdings Ltd
0.67
-0.47
-41.23%
HK:1161
Water Oasis Group
1.03
0.19
23.06%
HK:0919
Modern Healthcare Technology Holdings Limited
0.08
0.01
20.00%
HK:1830
Perfect Medical Health Management Limited
1.12
-0.78
-41.05%
HK:8603
Fameglow Holdings Limited
5.79
4.65
407.89%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 24, 2026